U0126 and PD98059, Specific Inhibitors of MEK, Accelerate Differentiation of RAW264.7 Cells into Osteoclast-like Cells

This publication has 47 references indexed in Scilit:

• Molecular interpretation of ERK signal duration by immediate early gene products
  Nature Cell Biology, 2002
• Involvement of p38 Mitogen-activated Protein Kinase Signaling Pathway in Osteoclastogenesis Mediated by Receptor Activator of NF-κB Ligand (RANKL)
  Journal of Biological Chemistry, 2000
• Receptor activator of NF‐κB recruits multiple TRAF family adaptors and activates c‐Jun N‐terminal kinase
  FEBS Letters, 1999
• RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in Osteoclastogenesis
  Biochemical and Biophysical Research Communications, 1998
• Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human Osteoclasts
  Journal of Biological Chemistry, 1996
• Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
  Science, 1995
• Molecular Cloning of Human cDNA for Cathepsin K: Novel Cysteine Proteinase Predominantly Expressed in Bone
  Biochemical and Biophysical Research Communications, 1995
• EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor
  Current Biology, 1994
• Growth factor‐stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1)
  FEBS Letters, 1994
• Osteoclasts express high levels of pp60c-src in association with intracellular membranes.
  The Journal of cell biology, 1992